Literature DB >> 12876285

Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP.

Chen Zhu1, Kavitha Rao, Huabao Xiong, Khatuna Gagnidze, Fengling Li, Curt Horvath, Scott Plevy.   

Abstract

Interleukin (IL)-12 is a heterodimeric cytokine that is critical for the development of a T-helper-1 immune response and immunity against intracellular pathogens. The IL-12 p40 gene product, expressed specifically in macrophages and dendritic cells, heterodimerizes with p35 to form bioactive IL-12, and heterodimerizes with p19 to comprise the cytokine IL-23. Regulation of the murine IL-12 p40 promoter is complex. Multiple cis-acting elements have been characterized that are involved in activation by bacterial products. However, molecular mechanisms through which interferon (IFN)-gamma and bacterial products synergistically activate IL-12 p40 gene expression are less clear. In this study, a composite NFAT/ICSBP binding site at -68 to -54 is identified that is functionally important for p40 promoter activation by lipopolysaccharide (LPS) and LPS plus IFN-gamma. DNA binding of NFAT and ICSBP is demonstrated on the endogenous promoter by chromatin immunoprecipitation. NFAT is required for ICSBP binding to this region. Overexpression of NFAT and ICSBP synergistically activates the p40 promoter. A dominant negative NFAT molecule attenuates LPS- and IFN-gamma-activated endogenous IL-12 p40 mRNA expression. A physical association between NFAT and ICSBP in the absence of DNA is detected by co-immunoprecipitation of endogenous proteins. Three NFAT domains are required for ICSBP interaction. Finally, in LPS- and IFN-gamma-activated RAW-264.7 cells, the association between NFAT and ICSBP is abrogated by IL-10 priming.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12876285     DOI: 10.1074/jbc.M306441200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.

Authors:  Jianguo Liu; Shanjin Cao; Sunjung Kim; Elaine Y Chung; Yoichiro Homma; Xiuqin Guan; Violeta Jimenez; Xiaojing Ma
Journal:  Curr Immunol Rev       Date:  2005-06

2.  NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G.

Authors:  Melissa A Farrow; Eun-Young Kim; Steven M Wolinsky; Ann M Sheehy
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

3.  Identification of two nuclear factor of activated T-cells (NFAT)-response elements in the 5'-upstream regulatory region of the ET-1 promoter.

Authors:  Kevin A Strait; Peter K Stricklett; Rachel M Kohan; Donald E Kohan
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

4.  Characterization of an interferon-stimulated response element (ISRE) in the Il23a promoter.

Authors:  Shehzad Z Sheikh; Taku Kobayashi; Katsuyoshi Matsuoka; Joseph C Onyiah; Scott E Plevy
Journal:  J Biol Chem       Date:  2010-11-21       Impact factor: 5.157

5.  Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways.

Authors:  Serena Ghisletti; Wendy Huang; Kristen Jepsen; Chris Benner; Gary Hardiman; Michael G Rosenfeld; Christopher K Glass
Journal:  Genes Dev       Date:  2009-03-15       Impact factor: 11.361

6.  IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.

Authors:  Amy V Paschall; Ruihua Zhang; Chen-Feng Qi; Kankana Bardhan; Liang Peng; Geming Lu; Jianjun Yang; Miriam Merad; Tracy McGaha; Gang Zhou; Andrew Mellor; Scott I Abrams; Herbert C Morse; Keiko Ozato; Huabao Xiong; Kebin Liu
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

Review 7.  IRF8 regulates myeloid and B lymphoid lineage diversification.

Authors:  Hongsheng Wang; Herbert C Morse
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

8.  NFATc1 mediates Toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection.

Authors:  Hisako Kayama; Ritsuko Koga; Koji Atarashi; Megumi Okuyama; Taishi Kimura; Tak W Mak; Satoshi Uematsu; Shizuo Akira; Hiroshi Takayanagi; Kenya Honda; Masahiro Yamamoto; Kiyoshi Takeda
Journal:  PLoS Pathog       Date:  2009-07-17       Impact factor: 6.823

9.  Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function.

Authors:  Andrea la Sala; Jianping He; Leopoldo Laricchia-Robbio; Stefania Gorini; Akiko Iwasaki; Michael Braun; George S Yap; Alan Sher; Keiko Ozato; Brian Kelsall
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

10.  Tocotrienols are good adjuvants for developing cancer vaccines.

Authors:  Sitti Rahma Abdul Hafid; Ammu Kutty Radhakrishnan; Kalanithi Nesaretnam
Journal:  BMC Cancer       Date:  2010-01-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.